Navigation Links
CeloNova BioSciences Introduces a New Class of Coronary Stent: The CATANIA(TM) Coronary Stent System with NanoThin Polyzene(R)-F
Date:1/19/2008

ATLANTA, Jan. 20 /PRNewswire/ -- CeloNova BioSciences, Inc. ("CeloNova"), leading and accelerating healthcare solutions through the development of innovative medical devices, today announced breakthrough results from the ATLANTA study of the CATANIA(TM) Coronary Stent System with NanoThin Polyzene(R)-F at the 20th Annual International Symposium on Endovascular Therapy (ISET).

(Photo: http://www.newscom.com/cgi-bin/prnh/20080120/CLSU002 )

Corrado Tamburino, MD, President of the Italian Society of Interventional Cardiology, Chief of Interventional Cardiology at Ferrarotto Hospital and Full Professor of Cardiology at the University of Catania is Principal Investigator for the ATLANTA study. Dr. Tamburino noted, "I perform many angioplasties in each single day, many, and I am totally impressed by the performance of this stent in a very complex patient population. No thrombosis. Low binary restenosis. No MIs. This may be an answer to the problems we are facing with other stent systems."

The CATANIA(TM) Stent System with NanoThin Polyzene(R)-F, dubbed "The CAT" by cardiologists who have used the product, has completed CE Marking and is available for sale anywhere the CE Mark is accepted. Advantages include:

-- Early and complete vessel healing, as early as 30 days.

-- Patients can discontinue dual anti-platelet therapy after only one

month.

-- Protection from stent thrombosis

-- The Polyzene(R)-F surface treatment is bacterial-resistant

"The FDA has cautioned physicians about a small but significant increased risk of stent thrombosis for patients with drug-eluting stents. Now, Britain's National Institute for Health and Clinical Excellence is considering restrictions on DES because they are not cost-effective for most patients and because of uncertainties about safety. Polyzene(R)-F seems to solicit a positive biologic
'/>"/>

SOURCE CeloNova BioSciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. CeloNova BioSciences Announces Positive Results from European Study of Embozene(TM) Microspheres for Treatment of Uterine Fibroids
2. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
3. ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells
4. Upstream Biosciences Acquires Innovative Platform Technology and Drug Candidates for Tropical Parasitic Diseases
5. Ardea Biosciences, Inc. Announces Completion of Phase 1 Clinical Trials of Novel Investigational HIV Drug RDEA806
6. Ardea Biosciences, Inc. Presents Results of Phase 1 Studies of RDEA806, a Novel NNRTI for HIV, at 47th ICAAC
7. Ardea Biosciences Lead MEK Inhibitor, RDEA119, to Enter Human Clinical Trials in Advanced Cancer Patients
8. Alacrity Biosciences Announces Positive Results from a Phase 2 Study of Its Dry Eye Treatment ALTY-0501
9. Sangamo BioSciences and Sigma-Aldrich Announce Nature Biotechnology Study Demonstrating Zinc Finger Technology for Modification of Human Stem Cells
10. Regado Biosciences Initiates Phase IIa Clinical Study of REG1 Anticoagulation System
11. Regado Biosciences Presents Positive Data From REG1 Anticoagulation System Phase Ic Study at American Heart Association 2007 Scientific Sessions

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)..., BASKINGRIDGE,N.J.,Nov.25/PRNewswire/--Regad...pmentofantithromboticaptamerswithactivecontrolagen...lbepresentingatthePiperJaffray21stAnnualHealthCare...Mazzo,spresentationwillbegivenat1:10pm(EST)onTuesd...pipelinewithemphasisontheleaddevelopmentprogram,th...
(Date:11/25/2009)..., NEWYORK,Nov.25/PRNewswire/--Reportlinker.co...nitscatalogue: ,, MammographyEquipment-AGloba...r.com/p0164330/Mammography-Equipment---A-Global-Ma...stcancerinindustrializedaswellasdevelopingnationsi...market.Globally,escalatingawarenessaboutbreastcanc...
(Date:11/25/2009)..., WALTHAM,Mass.,Nov.25/PRNewswire/--According...nmedicaltechnologymarketintelligence,thenearly$3bi...oseerapidgrowthoverthenextfiveyearsdespitetherecen... 2010 reportfindsthatthismarketwillremainhighlydyn...gspecializeddevicesinpreviouslyunderservedsegments...
Breaking Medicine Technology:Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 2Reportlinker Adds Mammography Equipment - A Global Market Perspective 2Reportlinker Adds Mammography Equipment - A Global Market Perspective 3Reportlinker Adds Mammography Equipment - A Global Market Perspective 4Reportlinker Adds Mammography Equipment - A Global Market Perspective 5Reportlinker Adds Mammography Equipment - A Global Market Perspective 6Reportlinker Adds Mammography Equipment - A Global Market Perspective 7US Trauma Fixation Device Market Not Seeing Signs of Slowdown 2US Trauma Fixation Device Market Not Seeing Signs of Slowdown 3Global Autoimmune Disease Therapeutics Market to Reach 2450 Billion by 2015 According to a New Report by Global Industry Analysts 50354 1Global Autoimmune Disease Therapeutics Market to Reach 2450 Billion by 2015 According to a New Report by Global Industry Analysts 50354 2Global Autoimmune Disease Therapeutics Market to Reach 2450 Billion by 2015 According to a New Report by Global Industry Analysts 50354 3Cell Therapeutics Added to Russell 3000 28R 29 Russell 2000 28R 29 and Russell Global 28R 29 Indexes 12836 1Cell Therapeutics Added to Russell 3000 28R 29 Russell 2000 28R 29 and Russell Global 28R 29 Indexes 12836 2Cell Therapeutics Added to Russell 3000 28R 29 Russell 2000 28R 29 and Russell Global 28R 29 Indexes 12836 3Your own private global warming 9061 1
(Date:11/26/2009)... No more letters from the North Pole, Textsanta....sages from Santa , North ...tional efficiencies at the North Pole Santa Claus ... all over the globe informed of his Christmas prog... research department have identified a large and g...
(Date:11/25/2009)....25/PRNewswire-USNewswire/--Whenmostpeoplehearthea...canalsogivepatientsthehelptheyneed.TMJstandsforthe...ble)contacts/connectswithyourskull(temporalbone). ...ctionarepainwithchewing,clickingorpoppingofthejaw....ncluding:headaches,fatigue,sleepdisturbances,irrit...
(Date:11/25/2009)....,Nov.25/PRNewswire/--Thanksgivingmealswillbedeliv...erLongBeachareathankstoFaithInAction/VolunteerActi...H),adivisionofSCANHealthPlan.Formorethan17yearsthe...eliverwarmThanksgivingmealstoseniorsinneedinLongBe...dsurroundingcities. ,, "Ourwarmholidaymealsared...
(Date:11/25/2009)...f testicular cancer who were treated with cisplati... including neurological side effects and Raynaud-l...chemotherapy, according to a new study published o...Cancer Institute . , Marianne Brydy, M.D., of th...pital, in Bergen, Norway, and colleagues conducted...
(Date:11/25/2009)... to fight rheumatoid arthritis, could help newly d...ESDAY, Nov. 25 (HealthDay News) -- A drug commonly...id arthritis now also shows some promise in helpin..., The drug, rituximab (Rituxan), helped patients...ough the disease had destroyed some of their pancr...
Breaking Medicine News(10 mins):Health News:Text Messages from Santa | Santa goes GREEN by going MOBILE for The March of Dimes 2Health News:SCAN Employees and Community Volunteers to Help Deliver One Thousand Thanksgiving Meals to Homebound Seniors 2Health News:Type 1 Diabetes May Have a New Foe 2Health News:Type 1 Diabetes May Have a New Foe 3
...fic pollution before getting a viral infection hav...80 percent of attacks are due to viruses -- most o...e discovered that exposure to nitrogen dioxide (NO...th up to 150 million people worldwide suffering fr...
...hing even more surprising - a cure for drug addict...amese advocates say it ends dependency on heroin, ...without side effects and without creating dependen...by any standard. The Vietnamese government is ...
...ike salmon, tuna or bluefish twice a week can prev...hms. It has long been known that eating fish is as...nly recently have researchers had scientific evide...e heart. Animal experiments demonstrate// that...
...d's economic market struggles to survive. Some of...y sector have created a new trend in products. Th...ices and gadgets. The gadgets are a weapon to fig...pular gadget is the spit bag. Priced at a tenth o...
...SARS on its border with hard-hit China. The fi... in Blagoveshchensk on the Amur river, which forms...t Hu Jintao tried to persuade the world his countr...read of the deadly virus and that its economy was ...
...ken a key step towards ensuring rapid action again...er threats to international public health. A resol...rld Health Organization’s (WHO) authority to verif...ot investigations to ensure it is appropriately co...
Other Medicine News:
SS-B (La) Anti-Extractable Nuclear Antigen (ENA) Antibodies Kit
ENA Single Well Screen
... designed with the proper sensitivity and specific...immune disease. Sera from over 2,000 patients with...re tested during the development of the RELISA ENA... to reference methods such as Ouchterlony immunodi...
...efense against foreign antigens and are usually cl...deposited in tissue and provoke inflammatory respo...osus (SLE), Rheumatoid Arthritis (RA) and may be i...n infectious and neoplastic diseases.,The princi...
Medicine Products: